Hello Avatar! Welcome to the BowtiedBiotech podcast, where science meets business! If you're fascinated by breakthrough biotech, bold innovations, and the business behind the science, you're in the right place. Each week, we dive into the world of biotech with fresh insights, sharp analysis, and the stories that are shaping the future of health. Whether you’re an industry insider, an investor, or just biotech-curious, we’ve got something for you.
We are now publishing 7x per week according to the following cadence:
Mondays: Stock Analysis & Biotech Catalysts
Tuesdays: Biotech hot topics (X-article)
Wednesdays: Podcast
Thursdays: Public & Private Biotech Markets
Fridays: Your Weekly Biotech Fix
Saturdays: Podcast
Sundays: Biotech Strategic Topics
We are also publishing unique content on X - be sure to follow up if you are not already @BowTiedBiotech. And to check-out the archive of our work on X you can find it on our website at: BowtiedBiotech.subtack.com/x-articles.
SUBSCRIBE TO PODCAST HERE:
Please help spread the work by subscribing and hitting the share button if you are enjoying content!
Welcome back to the Bowtied Biotech Podcast and to the official kickoff of 2025. For the biotech industry, the year doesn’t just begin—it launches—with JPMorgan. While much of the buzz surrounding this event has already made the rounds, we’re here to go beyond the headlines.
Today, we’ll uncover emerging trends from JPM 2025 that you might’ve missed. These aren’t just interesting observations—they’re the themes shaping the future of biotech.
We’re talking about:
Precision Immunology and its rapid rise in autoimmune and renal diseases.
TL1A evolving into a pipeline-in-a-pill with massive potential in inflammation and fibrosis.
Breakthroughs in Allergy Treatment that are rewriting the rules for IgE reduction.
Kidney as the New Liver, with therapies revolutionizing chronic kidney disease care.
Hepatic Scavengers via TPD, a new take on targeted protein degradation.
And Complement Combinations, where cutting-edge science is advancing next-gen therapies.
Whether you’re a scientist, investor, or just fascinated by the world of biotech, this episode will equip you with insights and strategies to stay ahead. Let’s dive into the trends defining the next chapter of innovation.
📣🎙️ TODAY’S PODCAST:
[ 0:02 ] Intro
[ 0:33 ] JPM 2025 Overview
[ 1:19 ] Precision Immunology
[ 4:01 ] TL1A
[ 6:25 ] Allergy Treatment Updates
[ 8:27 ] Kidney is the New Liver
[ 13:00 ] Complement Pathway
[ 19:53 ] Future of Biotech
[ 20:10 ] Neuro Needs Disruption
[ 25:07 ] Outro
CONCLUSION
We hope you are enjoying our first leap into the podcast world! Instead of waiting until everything is perfect, we’re diving in and will continue improving as we go. Feel free to send us your suggestions, feedback, or constructive criticism—we’d love to hear from you!
As a reminder, if looking to go deeper into the topics we cover check out our website BowTiedBiotech.com, or DM us on twitter, or email us: bowtiedbiotech@gmail.com
ABOUT BOWTIEDBIOTECH
As a reminder, the purpose of the BowTiedBiotech substack is two-fold. Primarily, we aim to provide our scientist audience the tools to build a biotech company and ultimately translate their ideas into medicines for patients. Secondarily, biotech investors may find this substack useful as we will be providing weekly market updates of the public AND private markets as well as heavily leveraging current financing events as teaching examples.
DISCLAIMER
None of this is to be deemed legal or financial advice of any kind. All updates are sourced from publicly available disclosures. Insights are *opinions* written by an anonymous cartoon/scientist/investor.
TOP BOWTIEDBIOTECH NEWSLETTERS
Share this post